|
Nipro Corporation is a medical device and pharmaceutical manufacturer operating through three business segments: Medical, Pharmaceutical, and Pharma Packaging. The Medical segment develops and manufactures medical devices and materials, including products for hemodialysis and vascular access, under brands such as Avanteck Vascular and InfraredeX. The Pharmaceutical segment focuses on the production of pharmaceuticals and raw materials, with key operations through Nipro Pharma and Zen'ei Pharmaceutical. The Pharma Packaging segment supplies medical glass containers and packaging solutions via subsidiaries like Nipro Pharma Packaging International. The company serves global markets with a presence in Asia, Europe, and the Americas, utilizing subsidiaries in Japan, Vietnam, Thailand, Brazil, Belgium, the United States, Singapore, China, India, Indonesia, France, and Germany. Nipro Corporation maintains a strategic partnership with Spryte Medical Holdings, LLC, holding a significant equity stake in the US-based medical technology firm. Summarised from the annual report, fiscal year ended Mar 2026 |
Industry Medical Devices | Homepage nipro.co.jp |
| Sector Healthcare | IR page nipro.co.jp | |
|
Tags
hemodialysis, vascular access, pharmaceuticals, medical glass, pharma packaging, medical devices, healthcare infrastructure, Nipro Iko, Goodman, Nipro Vietnam Company Limited, Nipro Thailand Corporation, Nipro Medical Ltda, Nipro Medical Europe N.V., Nipro Medical Corporation, Nipro Asia Pte Ltd., Nipro Trading (Shanghai) Co. Ltd., Nipro India Corporation Private Limited, Nipro Medical Devices (Hefei) Co. Ltd., PT. Nipro Indonesia JAYA, Avanteck Vascular Corporation, InfraredeX Inc., Nipro Pharma, Zen'ei Pharmaceutical Industry Co. Ltd., Nipro Pharma Vietnam Limited, Nipro Pharma Packaging International N.V., Nipro Pharmaceutical Packaging Containers (Shanghai) Co. Ltd., Nipro Medical Packaging Materials (Anyang) Co. Ltd., Nipro Pharma Packaging India Private Limited, Nipro Pharma Packaging Americas Corp., Nipro Pharma Packaging France S.A.S., Nipro Pharma Packaging Germany GmbH, Nisho Insurance Travel Co. Ltd., Nipro Europe Group Companies N.V., Nipro Digital Technologies Europe N.V., Nipro (China) Investment Co. Ltd., Nipro Americas Group Companies Inc., Spryte Medical Holdings LLC
|
Press page nipro.co.jp/ir/news |
Metrics
| Valuation | |
|---|---|
| Market cap | ¥ 253.268B |
| Market cap (USD) | $ 1.587B |
| P/E | 20.71 |
| PEG | 0.48 |
| P/BV | 0.68 |
| P/S | 0.37 |
| P/OCF | 5.07 |
| P/FCF | -11.83 |
| Dividend yield | 2.1% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 4.2% |
| ROI | 1.7% |
| ROIC | 2.5% |
| Profit margin | 2.0% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 43.5% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 3 |
| Quality score | 5.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 660.538B | 644.586B | 586.785B | 545.199B | 494.789B | 455.559B | 442.516B | 426.399B | 395.397B | 359.699B | 366.65B | 325.084B | 300.752B | 241.02B |
| Net profit | 13.504B | 5.113B | 11.109B | 4.574B | 13.455B | 14.209B | -12.281B | 12.136B | 11.829B | 11.346B | 19.718B | 12.47B | 2.861B | 10.231B |
| Free cash flow | -7.634B | -8.133B | -21.267B | -74.44B | -11.589B | 14.911B | -20.697B | -14.618B | -21.336B | -30.674B | -12.002B | — | — | — |
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 1.552K | 1.359K | 1.226K | 1.019K | 1.024K | 1.337K | 1.429K | 1.429K | 1.537K | 1.57K | 1.069K | 1.145K | 926.83 | 836.83 |
| Price performance 12m | 0.14 | 0.11 | 0.2 | -0 | -0.23 | -0.06 | 0 | -0.07 | -0.02 | 0.47 | -0.07 | 0.24 | 0.11 | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (JPY) | 121B | 141B | 149B | 152B | 141B | 281B | 321B | 320B | 334B | 351B |
| ↳ YoY growth | +6.9% | +16.1% | +6.0% | +2.3% | -7.8% | +99.7% | +14.2% | 0.0% | +4.1% | +5.3% |
| ↳ 5y CAGR | +4.4% | +18.3% | +17.9% | +16.6% | +17.0% | +20.1% | ||||
| Borrowings, current (JPY) | 143B | 129B | 143B | 137B | 136B | 153B | 143B | 185B | 157B | 197B |
| Borrowings, non-current (JPY) | 311B | 381B | 386B | 360B | 370B | 377B | 423B | 415B | 443B | 383B |
| Bonds payable (JPY) | 45.4B | 31.2B | 40B | 29.1B | 77.5B | 111B | 109B | 117B | 134B | 104B |
| Lease liabilities (JPY) | 3.98B | 3.74B | 6.73B | 13.2B | 32.1B | 29.5B | 29.7B | 30.1B | 31.8B | 28.6B |
| Cash and deposits (JPY) | 123B | 142B | 129B | 95.9B | 90.3B | 95.3B | 89.7B | 99.7B | 107B | 97.8B |
| Intangible assets (JPY) | 43.8B | 46B | 39.4B | 33.4B | 29.8B | 32.8B | 34B | 35.1B | 35.5B | 51.7B |
| Net debt (borrowings + leases - cash) (JPY) | 335B | 371B | 406B | 415B | 448B | 464B | 506B | 530B | 525B | 510B |
| Cash flow detail | ||||||||||
| Operating cash flow (JPY) | 33.5B | 41B | 41.4B | 37.2B | 66.1B | 68.2B | 10.4B | 72.9B | 68.5B | 54.7B |
| Purchases of property, plant and equipment (JPY) | -64.1B | -62.4B | -56B | -57.9B | -51.2B | -79.8B | -84.8B | -94.2B | -76.6B | -62.3B |
| Change in receivables (cash effect) (JPY) | -9.32B | -7.33B | -12.3B | -2.65B | 10.5B | 6.66B | -11.1B | 7.85B | 2.08B | -3.77B |
| Change in inventories (cash effect) (JPY) | -17.7B | -4.9B | -11.4B | -15.2B | -12.9B | -7.94B | -25B | -13.8B | -17.3B | -9.69B |
| Change in payables (cash effect) (JPY) | 4.58B | -3.82B | 11.8B | 205M | -567M | 704M | -5.78B | 272M | -2.58B | -1.97B |
| Dividends paid (cash effect) (JPY) | -4.07B | -6.48B | -4.95B | -3.66B | -1.72B | -5.22B | -4.25B | -3.03B | -4.41B | -3.76B |
| Share buybacks (cash effect) (JPY) | -5B | -1M | -5B | -8M | -699M | -2M | -1M | -34M | -7M | -17M |
| Interest paid (cash effect) (JPY) | -3.91B | -3.3B | -3.21B | -3.2B | -3.87B | -3.98B | -4.25B | -6.27B | -7.83B | -9.28B |
| Income taxes paid (cash effect) (JPY) | -7.31B | -7.33B | -8.18B | -9.11B | -7.07B | -6.09B | -9.57B | -9.07B | -13.2B | -10.4B |
| Operating cash flow before change in receivables (JPY) | 42.8B | 48.4B | 53.6B | 39.9B | 55.6B | 61.6B | 21.5B | 65.1B | 66.4B | 58.4B |
| Free cash flow (OCF - PPE - intangibles) (JPY) | -30.7B | -21.3B | -14.6B | -20.7B | 14.9B | -11.6B | -74.4B | -21.3B | -8.13B | -7.63B |
| Income detail | ||||||||||
| Research and development expense (JPY) | 11.5B | 16.1B | 16.5B | 18.2B | 18.7B | 18.7B | 19.7B | 20.8B | 21.7B | 26.8B |
| ↳ 5y CAGR | +12.7% | +10.2% | +4.1% | +4.8% | +3.5% | +7.5% | ||||
| Total comprehensive income (JPY) | 10.8B | 13.5B | -1.84B | -8.85B | 14.8B | 32B | 26B | 29.9B | 26.3B | 27.3B |
| Comprehensive income to owners (JPY) | 10.8B | 13B | -1.32B | -9.04B | 13.8B | 30B | 24.8B | 28.7B | 24.4B | 25.2B |
| Provision for credit losses (JPY) | 303M | 157M | 187M | 610M | 3.02B | 1.15B | 1.58B | 1.65B | 1.99B | 990M |
| Credit cost ratio (credit losses / average receivables) (%) | 0.3% | 0.1% | 0.1% | 0.4% | 2.1% | 0.5% | 0.5% | 0.5% | 0.6% | 0.3% |
| Segments | ||||||||||
| Pharma Packaging · Segment revenue (JPY) | 28.3B | 28.5B | 40.6B | 41.9B | 44.8B | 52.5B | 57.7B | 64.3B | 66.1B | 62B |
| ↳ YoY growth | -14.3% | +0.5% | +42.7% | +3.1% | +7.0% | +17.2% | +10.0% | +11.4% | +2.8% | -6.2% |
| Pharma Packaging · Segment operating income (JPY) | -1.31B | -1.31B | 778M | 675M | 1.99B | 2.89B | 2.74B | 2.45B | -272M | -1.59B |
| Reported | Jun 28, 2017 | Jun 27, 2018 | Jun 26, 2019 | Jun 26, 2020 | Jun 30, 2021 | Jun 28, 2022 | Jun 28, 2023 | Jun 26, 2024 | Jun 25, 2025 | Jun 25, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpTimely disclosures published on TDnet, newest first, titles as filed in Japanese. The link opens the disclosure on TDnet. Filings with EDINET (periodic reports, extraordinary reports, offerings, holding and buy-back reports), newest first, titles as filed in Japanese. The link opens the filing on EDINET. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Nipro Corporation
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVDV | 0.21% | 4,694,700 | $ 41.643M | Nov 16, 2026 |
| DISV | 0.09% | 534,300 | $ 4.558M | Nov 12, 2026 |
| AVDS | 0.06% | 24,600 | $ 218.209K | Nov 16, 2026 |
| DFIS | 0.05% | 341,400 | $ 2.912M | Nov 12, 2026 |
| AVSD | 0.03% | 13,300 | $ 117.975K | Nov 16, 2026 |
| DFIC | 0.02% | 368,406 | $ 3.143M | Nov 12, 2026 |
| AVDE | 0.02% | 364,000 | $ 3.229M | Nov 16, 2026 |
| DXIV | 0.02% | 5,600 | $ 47.77K | Nov 12, 2026 |
| DFAX | 0.01% | 144,700 | $ 1.234M | Nov 12, 2026 |
| DFAI | 0.01% | 160,594 | $ 1.37M | Nov 12, 2026 |



